Company invites individual and institutional investors to attend interactive real-time virtual presentation  

NEW YORK, April 5, 2016 /CNW/ — ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of…